CoreAge Rx vs Pallas Health

The verdict

CoreAge Rx edges out Pallas Health on the Editors' Rating, 94 to 78 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.

Pallas Health is still a genuine option — pallas Health is a rare thing in this category: a platform that sells both the inexpensive compounded route and the genuine FDA-approved pens, and is straightforward about the price of each. Compounded semaglutide averages about $199 a month and tirzepatide $299, while brand Zepbound is $1,069, Ozempic $1,299, and Wegovy and Mounjaro $1,349 each, all cash-pay. Its own FAQ answers the question that matters most on a titration schedule — does the price rise with the dose — with a flat no, and the clinician, dose adjustments, check-ins and messaging are all inside the plan price with no membership fee. Three separate claims held up under independent checking: two named clinicians are active in the federal NPI registry, the LegitScript seal returns a live image where an invented ID returns an error, and no FDA warning letter is attributable to the company. The reservations are specific rather than sweeping — billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is not billed at all. Weigh the six factors below against your own priorities.